β-Defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Jansen, Patrick A M ^a   Rodijk Olthuis, Diana ^a   Hollox, Edward J ^b   Kamsteeg, Marijke ^a   Tjabringa, Geuranne S ^a   de Jongh, Gys J ^a   van Vlijmen Willems, Ivonne M J J ^a   Bergboer, Judith G M ^a   van Rossum, Michelle M ^a   de Jong, Elke M G J ^a   den Heijer, Martin ^c   Evers, Andrea W M ^c   Bergers, Mieke ^a   Armour, John A L ^d   Zeeuwen, Patrick L J M ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; MESSENGER RNA; BETA DEFENSIN; BIOLOGICAL MARKER; DEFB4 PROTEIN, HUMAN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE ACTIVITY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PSORIASIS; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SKIN DEFECT; AGED; BLOOD; GENE DOSAGE; MIDDLE AGED; SKIN; VASCULARIZATION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BETA-DEFENSINS; BIOLOGICAL MARKERS; DERMATITIS, ATOPIC; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SKIN;

EID: 62749127946     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004725     Document Type: Article

References (51)

1. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5: 699-711.
2. Nickoloff BJ, Qin JZ, Nestle FO (2007) Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 33: 45-56.
3. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, et al. (2006) Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 78: 827-851.
4. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80: 273-290.
5. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, et al. (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122: 201-206.
6. Menssen A, Trommler P, Vollmer S, Schendel D, Albert E, et al. (1995) Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 155: 4078-4083.
7. Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, et al. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-{alpha} production. J Exp Med 202: 135-143.
8. Nickoloff BJ, Xin H, Nestle FO, Qin JZ (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25: 568-573.
9. Harder J, Bartels J, Christophers E, Schroder JM (1997) A peptide antibiotic from human skin. Nature 387: 861.
10. de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, et al. (2005) High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125: 1163-1173.
11. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347: 1151-1160.
12. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, et al. (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112: 1195-1202.
13. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171: 3262-3269.
14. Cookson W (2004) The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 4: 978-988.
15. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38: 441-446.
16. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40: 23-25.
17. de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, et al. (2009) Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41: 211-215.
18. Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Kamsteeg M, Verhoosel RM, et al. (2008) Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients. PLoS ONE 3: e2301.
19. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720
20. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, et al. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
21. Niyonsaba F, Ogawa H, Nagaoka I (2004) Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111: 273-281.
22. Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa H, Nagaoka I (2002) Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 14: 421-426.
23. Hollox EJ, Armour JA, Barber JC (2003) Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 73: 591-600.
24. Harder J, Schroder JM (2005) Antimicrobial peptides in human skin. Chem Immunol Allergy 86: 22-41.
25. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, et al. (2002) Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118: 275-281.
26. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32: 982-986.
27. Gallo RL, Murakami M, Ohtake T, Zaiou M (2002) Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 110: 823-831.
28. Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361: 151-160.
29. Hoogendoorn EH, Hermus AR, de Veght F, Ross HA, Verbeek AL, et al. (2006) Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 52: 104-111.
30. Schmitt J, Wozel G (2005) The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 210: 194-199.
31. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, et al. (1997) Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195: 10-19.
32. van Riel PL, Schumacher HR Jr (2001) How does one assess early rheumatoid arthritis in daily clinical practice? Best Pract Res Clin Rheumatol 15: 67-76.
33. Alkemade HA, Molhuizen HO, van Vlijmen-Willems IM, van Haelst UJ, Schalkwijk J (1993) Differential expression of SKALP/Elafin in human epidermal tumors. Am J Pathol 143: 1679-1687.
34. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
35. Armour JA, Palla R, Zeeuwen PL, den Heijer M, Schalkwijk J, et al. (2007) Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Nucleic Acids Res 35: e19.
36. Tjabringa G, Bergers M, van Rens D, de Boer R, Lamme E, et al. (2008) Development and validation of human psoriatic skin equivalents. Am J Pathol 173: 815-823.
37. Gallagher WH, Woodward CK (1989) The concentration dependence of the diffusion coefficient for bovine pancreatic trypsin inhibitor: a dynamic light scattering study of a small protein. Biopolymers 28: 2001-2024.
38. Schalkwijk J, Lamme E, de Jongh G, Zeeuwen P, Bergers M (2006) Psoriatic Skin Equivalents. Patent application WO2007073151.
39. Yang D, Chen Q, Chertov O, Oppenheim JJ (2000) Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 68: 9-14.
40. Alkemade HA, de Jongh GJ, Arnold WP, van de Kerkhof PC, Schalkwijk J (1995) Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A. J Invest Dermatol 104: 189-193.
41. Anderson KS, Wong J, Polyak K, Aronzon D, Enerback C (2008) Detection of psoriasin/S100A7 in the sera of patients with psoriasis. Br J Dermatol, e-pub ahead of print.
42. Laurent MR, Panayi GS, Shepherd P (1981) Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis. Ann Rheum Dis 40: 66-69.
43. Howell MD, Boguniewicz M, Pastore S, Novak N, Bieber T, et al. (2006) Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 121: 332-338.
44. Yang D, Biragyn A, Kwak LW, Oppenheim JJ (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23: 291-296.
45. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, et al. (2002) Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298: 1025-1029.
46. Di Nardo A, Braff MH, Taylor KR, Na C, Granstein RD, et al. (2007) Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol 178: 1829-1834.
47. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569.
48. Braff MH, Hawkins MA, Di Nardo A, Lopez-Garcia B, Howell MD, et al. (2005) Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 174: 4271-4278.
49. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, et al. (2006) A chromosome 8 gene-cluster polymorphism with low human Beta-defensin 2 gene copy number predisposes to crohn disease of the colon. Am J Hum Genet 79: 439-448.
50. Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, et al. (2005) Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 37: 1341-1344.
51. Bals R, Wang X, Wu Z, Freeman T, Bafna V, et al. (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102: 874-880.